Cart
sales@molnova.com
Arg-Gly-Asp-Ser (TFA)
CAS No. ——
Arg-Gly-Asp-Ser (TFA)( RGDS peptide (TFA); Fibronectin tetrapeptide (TFA) )
Catalog No. M29742 CAS No. ——
Arg-Gly-Asp-Ser (TFA) is an integrin binding sequence that inhibits integrin receptor function.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameArg-Gly-Asp-Ser (TFA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionArg-Gly-Asp-Ser (TFA) is an integrin binding sequence that inhibits integrin receptor function.
-
DescriptionArg-Gly-Asp-Ser (TFA) is an integrin binding sequence that inhibits integrin receptor function.
-
In Vitro——
-
In Vivo——
-
SynonymsRGDS peptide (TFA); Fibronectin tetrapeptide (TFA)
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight547.44
-
Molecular FormulaC17H28F3N7O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Arg-Gly-Asp-Ser
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Aguzzi MS, et al. Intracellular targets of RGDS peptide in melanoma cells. Mol Cancer. 2010 Apr 22;9:84.
molnova catalog
related products
-
Planispine A
Planispine A has Anti-inflammatory activity.
-
AKOS037652256
AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.
-
Setmelanotide TFA
Setmelanotide TFA (RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA) is a selective melanocortin 4 receptor (MC4R) agonist.
